Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Adverse Outcome
13%
All Cause Mortality
30%
Apoplexy
28%
Artificial Intelligence
11%
Atrial Fibrillation
80%
Biological Marker
12%
Brain Ischemia
11%
Brugada Syndrome
51%
Cardiac Dysrhythmia
18%
Cardiovascular Disease
34%
Cardiovascular System
20%
Cardiovascular System
12%
Cohort Analysis
32%
Comorbidity
11%
Congestive Heart Failure
60%
COVID-19
22%
Diabetes
10%
Diabetes Mellitus
26%
Diseases
13%
Ejection Fraction
14%
Electrocardiogram
28%
Electrocardiography
12%
Faintness
17%
Hazard Ratio
31%
Heart Atrium Remodeling
10%
Heart Failure with Preserved Ejection Fraction
13%
Heart Left Ventricle Ejection Fraction
18%
Heart Ventricle Arrhythmia
22%
Malignant Neoplasm
19%
Maturity Onset Diabetes of the Young
28%
Meta-Analysis
100%
Myocardial Infarction
17%
New-Onset Atrial Fibrillation
15%
Observational Study
16%
Odds Ratio
26%
P Wave
13%
Patient with Type 2 Diabetes
15%
Percutaneous Coronary Intervention
13%
Proportional Hazards Model
17%
Prospective Cohort Study
14%
Prostate Cancer
12%
Randomized Controlled Trial
12%
Repolarization
21%
Risk Stratification
46%
Sudden Cardiac Death
29%
Systematic Review
94%
T-Peak to T-End
10%
Ventricular Fibrillation
14%
Ventricular Outflow Tract
11%
Ventricular Tachycardia
20%
Pharmacology, Toxicology and Pharmaceutical Science
All Cause Mortality
45%
Antiarrhythmic Agent
10%
Arrhythmogenesis
22%
Atherosclerosis
14%
Atrial Fibrillation
99%
Biological Marker
11%
Brain Ischemia
9%
Brugada Syndrome
18%
Cardiovascular Disease
29%
Cardiovascular Mortality
11%
Cardiovascular Risk
13%
Cerebrovascular Accident
27%
Cohort Study
53%
Combination Therapy
9%
Comorbidity
9%
Congestive Heart Failure
72%
Coronavirinae
14%
Diabetes Mellitus
47%
Dipeptidyl Peptidase IV Inhibitor
20%
Disease
14%
Diseases
21%
Fibrosis
10%
Heart Arrhythmia
40%
Heart Atrium Remodeling
22%
Heart Failure with Preserved Ejection Fraction
9%
Heart Infarction
16%
Heart Ventricle Arrhythmia
28%
Heart Ventricle Remodeling
10%
Heart Ventricle Tachycardia
15%
Hemoglobin A1c
9%
Heptanol
13%
Hypertension
11%
Immune Checkpoint Inhibitor
14%
Inflammation
9%
Leporidae
13%
Long QT Syndrome
12%
Malignant Neoplasm
27%
Maturity Onset Diabetes of the Young
15%
Metformin
10%
Myocardial Disease
9%
New-Onset Atrial Fibrillation
14%
Non Insulin Dependent Diabetes Mellitus
14%
Observational Study
19%
Prostate Cancer
14%
Randomized Controlled Trial
25%
Recurrent Disease
13%
Sodium Glucose Cotransporter 2 Inhibitor
17%
sodium glucose cotransporter-2 inhibitors
20%
Sudden Cardiac Death
30%
Warfarin
11%
Biochemistry, Genetics and Molecular Biology
Action Potential
12%
Action Potential Duration
5%
All Cause Mortality
13%
APD90
5%
Atrial Fibrillation
62%
Body Mass
6%
Brugada Syndrome
19%
C-Reactive Protein
7%
Cardiac Dysrhythmia
16%
Cardiac Muscle Cell
9%
Cardiovascular Mortality
5%
Cohort Study
20%
Electrocardiogram
8%
Endoplasmic Reticulum Stress
10%
Genetics
5%
Heart Ejection Fraction
6%
Heart Left Ventricle Ejection Fraction
5%
Heptanol
11%
Hypokalemia
5%
Ion Channel
7%
Leporidae
7%
Leukocyte
5%
Maturity Onset Diabetes of the Young
6%
Medline
8%
Mendelian Randomization
5%
Mitochondrial Disorder
11%
Observational Study
7%
Oxidative Stress
18%
Prospective Cohort Study
7%
Rat
5%
Repolarization
15%
Signal Transduction
8%
Sodium Channel
6%
Sudden Cardiac Death
6%
Systolic Blood Pressure
5%
Ventricular Tachycardia
8%